MedPath

Novo Nordisk Pharmaceutical Industries, LP

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Mixed Protamine Recombinant Human Insulin Injection(30R)

Product Name
诺和灵30R
Approval Number
S20201001
Approval Date
Feb 5, 2020
NMPA

Mixed Protamine Recombinant Human Insulin Injection(30R)

Product Name
诺和灵30R
Approval Number
S20201006
Approval Date
Feb 5, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.